Global Spinal Cord Stimulation Market: Industry Analysis & Outlook (2017-2021)
Spinal cord stimulation (SCS) is a therapy for people who are not relieved from back or neck pain by surgeries and other treatments. It helps to treat pain by hiding pain signals before reaching brain. A device is implanted in body to deliver the signals to spinal cord. Battery attached to pulse generator are of two types, non-rechargeable and rechargeable batteries for the power demand of device.
Failed back surgery is the most common reason for spinal cord stimulation surgery. SCS is a two step process to determine whether spinal cord stimulation will work for the patients or not. Trial spinal cord stimulation is a test drive to determine if therapy will provide pain relief to the patient or not. After the implantation in trial, patient considers the permanent implantation of device based on pain relief improvement.
The U.S. is the main contributor to the SCS market with increasing chronic back pain prevalence and rising addressable population for SCS. The U.S. has great potential in the years ahead with favorable reimbursement policies and improved health service quality. The growth of SCS outside the U.S. is driven by increasing awareness and need for new therapies and devices. The market is relatively small due to lack of reimbursements, that limits the growth of the market.
The global SCS market is expected to grow in future due to growing ageing population, increase in health care expenditure and rising obese population. Key trends of this market include favorable reimbursement landscape in the U.S., launch of new products, awareness regarding early treatments, increase in trial SCS treatments, increasing demand for minimally invasive surgeries, increase SCS for predominant back pain and rising mergers & acquisitions activities. However, high cost of treatment, tough regulatory problems and dependency on traditional therapies are some of the factors posing challenge for the market growth.
The report “Global Spinal Cord Stimulation Market: Industry Analysis & Outlook (2017-2021)” by Koncept Analytics provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers and challenges of the market, covering the U.S. and Outside the U.S. region. The report profiles the key players of the market including Nevro Corporation, Medtronic Plc., Abbott Laboratories (St. Jude) and Boston Scientific.
Failed back surgery is the most common reason for spinal cord stimulation surgery. SCS is a two step process to determine whether spinal cord stimulation will work for the patients or not. Trial spinal cord stimulation is a test drive to determine if therapy will provide pain relief to the patient or not. After the implantation in trial, patient considers the permanent implantation of device based on pain relief improvement.
The U.S. is the main contributor to the SCS market with increasing chronic back pain prevalence and rising addressable population for SCS. The U.S. has great potential in the years ahead with favorable reimbursement policies and improved health service quality. The growth of SCS outside the U.S. is driven by increasing awareness and need for new therapies and devices. The market is relatively small due to lack of reimbursements, that limits the growth of the market.
The global SCS market is expected to grow in future due to growing ageing population, increase in health care expenditure and rising obese population. Key trends of this market include favorable reimbursement landscape in the U.S., launch of new products, awareness regarding early treatments, increase in trial SCS treatments, increasing demand for minimally invasive surgeries, increase SCS for predominant back pain and rising mergers & acquisitions activities. However, high cost of treatment, tough regulatory problems and dependency on traditional therapies are some of the factors posing challenge for the market growth.
The report “Global Spinal Cord Stimulation Market: Industry Analysis & Outlook (2017-2021)” by Koncept Analytics provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers and challenges of the market, covering the U.S. and Outside the U.S. region. The report profiles the key players of the market including Nevro Corporation, Medtronic Plc., Abbott Laboratories (St. Jude) and Boston Scientific.
1. MARKET OVERVIEW
1.1 Introduction
1.2 Spinal Cord Stimulation Devices
1.3 Conditions for SCS Treatment
1.4 Spinal Cord Stimulation Therapies
1.5 Surgical Procedures
2. GLOBAL SPINAL CORD STIMULATION (SCS) MARKET
2.1 Global SCS Market Forecast by Value
2.2 Global SCS Market by Region
2.3 Global SCS Addressable Population Forecast
2.4 Global SCS System Implant Volume Forecast
3. REGIONAL MARKET
3.1 The U.S.
3.1.1 The U.S. Chronic Back Pain Prevalence Forecast
3.1.2 The U.S. SCS Market Forecast by Value
3.1.3 The U.S. Addressable SCS Population Forecast
3.1.4 The U.S. SCS System Implant Volume Forecast
3.2 Outside the U.S.
3.2.1 Outside the U.S. SCS Market Forecast by Value
3.2.2 Outside the U.S. SCS Addressable Population Forecast
3.2.3 Outside the U.S. SCS System Implant Volume Forecast
3.2.4 Outside the U.S. Rechargeable SCS Market Forecast by Value
4. MARKET DYNAMICS
4.1 Growth Drivers
4.1.1 Rising Ageing Population
4.1.2 Increasing Healthcare Spending
4.1.3 Rising GDP Per Capita
4.1.4 Increase in Obese Population
4.2 Key Trends & Developments
4.2.1 Increase in Trial Units for SCS in the U.S.
4.2.2 Mergers and Acquisitions
4.2.3 Increasing SCS Implants for Predominant Back Pain in the U.S.
4.2.4 Accelerating Use of Percutaneous Lead Technology in SCS Treatments
4.2.5 Increasing Demand for Minimally Invasive Devices
4.2.6 Rising Awareness of Early Treatment for Chronic Pain
4.2.7 New Product Launches
4.2.8 Burden of Chronic Pain in the U.S.
4.2.9 Favorable Reimbursement Policies in the U.S.
4.3 Challenges
4.3.1 Dependence on Traditional Therapies
4.3.2 High Cost Related to SCS Treatment
4.3.3 Tough Regulatory Problems
5. COMPETITIVE LANDSCAPE
5.1 Global SCS Market
5.1.1 Revenue and Market Cap Comparison
5.1.2 Global SCS Market Share by Company
5.1.3 Key SCS Product Comparison by Company
5.2 Regional SCS Market
5.2.1 The U.S. SCS Market Share by Company
5.2.2 Outside the U.S. SCS Market Share by Company
6. COMPANY PROFILES
6.1 Nevro Corporation
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies
6.2 Medtronic Plc
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies
6.3 Boston Scientific
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies
6.4 Abbott Laboratories (St. Jude Medical)
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies
1.1 Introduction
1.2 Spinal Cord Stimulation Devices
1.3 Conditions for SCS Treatment
1.4 Spinal Cord Stimulation Therapies
1.5 Surgical Procedures
2. GLOBAL SPINAL CORD STIMULATION (SCS) MARKET
2.1 Global SCS Market Forecast by Value
2.2 Global SCS Market by Region
2.3 Global SCS Addressable Population Forecast
2.4 Global SCS System Implant Volume Forecast
3. REGIONAL MARKET
3.1 The U.S.
3.1.1 The U.S. Chronic Back Pain Prevalence Forecast
3.1.2 The U.S. SCS Market Forecast by Value
3.1.3 The U.S. Addressable SCS Population Forecast
3.1.4 The U.S. SCS System Implant Volume Forecast
3.2 Outside the U.S.
3.2.1 Outside the U.S. SCS Market Forecast by Value
3.2.2 Outside the U.S. SCS Addressable Population Forecast
3.2.3 Outside the U.S. SCS System Implant Volume Forecast
3.2.4 Outside the U.S. Rechargeable SCS Market Forecast by Value
4. MARKET DYNAMICS
4.1 Growth Drivers
4.1.1 Rising Ageing Population
4.1.2 Increasing Healthcare Spending
4.1.3 Rising GDP Per Capita
4.1.4 Increase in Obese Population
4.2 Key Trends & Developments
4.2.1 Increase in Trial Units for SCS in the U.S.
4.2.2 Mergers and Acquisitions
4.2.3 Increasing SCS Implants for Predominant Back Pain in the U.S.
4.2.4 Accelerating Use of Percutaneous Lead Technology in SCS Treatments
4.2.5 Increasing Demand for Minimally Invasive Devices
4.2.6 Rising Awareness of Early Treatment for Chronic Pain
4.2.7 New Product Launches
4.2.8 Burden of Chronic Pain in the U.S.
4.2.9 Favorable Reimbursement Policies in the U.S.
4.3 Challenges
4.3.1 Dependence on Traditional Therapies
4.3.2 High Cost Related to SCS Treatment
4.3.3 Tough Regulatory Problems
5. COMPETITIVE LANDSCAPE
5.1 Global SCS Market
5.1.1 Revenue and Market Cap Comparison
5.1.2 Global SCS Market Share by Company
5.1.3 Key SCS Product Comparison by Company
5.2 Regional SCS Market
5.2.1 The U.S. SCS Market Share by Company
5.2.2 Outside the U.S. SCS Market Share by Company
6. COMPANY PROFILES
6.1 Nevro Corporation
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies
6.2 Medtronic Plc
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies
6.3 Boston Scientific
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies
6.4 Abbott Laboratories (St. Jude Medical)
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies
LIST OF CHARTS
Types of Electrical Stimulation For Chronic Pain
Global SCS Market Forecast by Value (2016-2021)
Global SCS Market by Region (2016)
Global SCS Addressable Population Forecast (2016-2021)
Global SCS System Implant Volume Forecast (2016-2021)
The U.S. Chronic Back Pain Prevalence Forecast (2016-2021)
The U.S. SCS Market Forecast by Value (2016-2021)
The U.S. Addressable SCS Population Forecast (2016-2021)
The U.S. SCS System Implant Volume Forecast (2016-2021)
OUS SCS Market Forecast by Value (2016-2021)
OUS SCS Addressable Population Forecast (2016-2021)
OUS SCS System Implant Volume Forecast (2016-2021)
OUS Rechargeable SCS Market Forecast by Value (2016-2021)
Global Ageing Population (2012-2016)
Global Healthcare Spending Per Capita (2012-2016)
Global GDP Per Capita (2012-2016)
Global Obese Population (2012-2016)
Increase Trial Units for SCS in the U.S. (2016-2021)
The U.S. SCS Implant Volume by Pain Location (2016)
The U.S. (2016)
Outside the U.S. (2016)
Global SCS Market Share by Company (2016/2020E)
The U.S. SCS Market Share by Company (2016)
Outside the U.S. SCS Market Share by Company (2016)
Nevro Corporation Revenue by Region (2016)
Nevro Corporation Revenue and Net Loss (2012-2016)
Nevro Corporation R&D Expenditure (2012-2016)
Medtronic Plc Revenue by Segment (2017*)
Medtronic Plc Net Revenue and Net Profit (2013-2017*)
Boston Scientific Revenue by Segment (2016)
Boston Scientific’s Revenue and Annual Growth (2012-2016)
Abbott Laboratories Revenue by Segment (2016)
Abbott Laboratories Revenue and Net Income (2012-2016)
Abbott Laboratories R&D Expenditure (2012-2016)
Types of Electrical Stimulation For Chronic Pain
Global SCS Market Forecast by Value (2016-2021)
Global SCS Market by Region (2016)
Global SCS Addressable Population Forecast (2016-2021)
Global SCS System Implant Volume Forecast (2016-2021)
The U.S. Chronic Back Pain Prevalence Forecast (2016-2021)
The U.S. SCS Market Forecast by Value (2016-2021)
The U.S. Addressable SCS Population Forecast (2016-2021)
The U.S. SCS System Implant Volume Forecast (2016-2021)
OUS SCS Market Forecast by Value (2016-2021)
OUS SCS Addressable Population Forecast (2016-2021)
OUS SCS System Implant Volume Forecast (2016-2021)
OUS Rechargeable SCS Market Forecast by Value (2016-2021)
Global Ageing Population (2012-2016)
Global Healthcare Spending Per Capita (2012-2016)
Global GDP Per Capita (2012-2016)
Global Obese Population (2012-2016)
Increase Trial Units for SCS in the U.S. (2016-2021)
The U.S. SCS Implant Volume by Pain Location (2016)
The U.S. (2016)
Outside the U.S. (2016)
Global SCS Market Share by Company (2016/2020E)
The U.S. SCS Market Share by Company (2016)
Outside the U.S. SCS Market Share by Company (2016)
Nevro Corporation Revenue by Region (2016)
Nevro Corporation Revenue and Net Loss (2012-2016)
Nevro Corporation R&D Expenditure (2012-2016)
Medtronic Plc Revenue by Segment (2017*)
Medtronic Plc Net Revenue and Net Profit (2013-2017*)
Boston Scientific Revenue by Segment (2016)
Boston Scientific’s Revenue and Annual Growth (2012-2016)
Abbott Laboratories Revenue by Segment (2016)
Abbott Laboratories Revenue and Net Income (2012-2016)
Abbott Laboratories R&D Expenditure (2012-2016)
LIST OF TABLES
Mergers and Acquisitions (2016-2017)
Key Players - Revenue & Market Cap Comparison (2016)
Key SCS Product Comparison by Company (2016)
Mergers and Acquisitions (2016-2017)
Key Players - Revenue & Market Cap Comparison (2016)
Key SCS Product Comparison by Company (2016)
